Altogether, these data suggest that FGF2 expression is elevated in multiple pulmonary cell types in asthma and COPD, and may be involved in the pathogenesis of chronic inflammatory airway diseases. This evidence concerns the gene FGF2 and chronic obstructive pulmonary disease.